Yaz Settlements Reached in 500 Lawsuits: Report

Bayer has reportedly agreed to pay $110 million to settle about 500 lawsuits over the side effects of its Yaz and Yasmin birth control pills

Details of the Yaz settlements were leaked to Bloomberg News, which reported that the average came to about $220,000 per plaintiff.

Bayer currently faces more than 10,000 Yaz lawsuits and Yasmin lawsuits being pursued by women throughout the United States who allege that the drug maker failed to adequately warn about the risk of blood clots associated with the birth control pills.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The details come about a month after Bayer reported that it had reached agreements to settle Yaz and Yasmin lawsuits brought by at least 70 women who had filed Yaz and Yasmin claims.

The claims center on the side effects of drospirenone, a newer type of progestin that is used in the oral contraceptives in combination with estrogen.  It was first introduced in Yasmin birth control by Berlex Laboratories, which was later acquired by Bayer.  Yaz is an updated version of the birth control pill, and Bayer recently introduced a third variation, marketed as Beyaz, which also includes a folate supplement.

Several studies have suggested that women taking Yaz or other drospirenone-based birth control pills face an increased risk of blood clots, stroke, pulmonary embolism, deep vein thrombosis and sudden death.

The settlement information comes just days after the FDA announced that it was requiring all drospirenone-based birth control pills to carry additional warnings that they might increase the risk of blood clots when compared to some other birth control pills.

The revised labels will state that some studies report that drospirenone-based birth control pills may triple the risk of blood clots when compared to pills containing other progestins, but notes that some studies found no increased risk. The labels will include data from the FDA’s own study, which determined that drospirenone-based birth control pills were associated with a 1.5-fold increase in blood clot risk.

Earlier this year, the federal judge presiding over all lawsuits filed in U.S. District Courts throughout the United States ordered Bayer and plaintiffs’ lawyers to engage in Yaz settlement negotiations before the first cases are submitted to a jury.  Known as bellwethers, those early trial dates are often used to facilitate discussions to settle other lawsuits, and may help the parties gauge how juries are likely to respond to evidence that is likely to be introduced in multiple cases.

1 Comments

  • ConnieApril 20, 2012 at 11:25 pm

    I keep hearing the bayer has reached settlement with yasmin, does any one know when we will receive settlement checks?" I suffered conjestive heart failure in 2007 and almost died. Cant get a lot of info out of my attorney at this time.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.